a receptor tyrosine kinase that binds insulin-like growth factor 1 (IGF1) with a high affinity and IGF2 with a lower affinity. Functions as an anti-apoptotic agent by enhancing cell survival. Can play a critical role in transformation events. Cleavage of the precursor generates alpha and beta subunits. Tetramer of 2 alpha and 2 beta chains linked by disulfide bonds. The alpha chains contribute to the formation of the ligand- binding domain, while the beta chain carries the kinase domain. Interacts with PIK3R1 and with the PTB/PID domains of IRS1 and SHC1 in vitro when autophosphorylated on tyrosine residues. Mutated in rare cases of pre- and post-natal growth retardation. One SNP associated with increased human longevity. Increased expression of IGF1R and other pathway members associated with progression and malignancy in a range of cancers. Inhibitors: AG1024, AEW541. Note: This description may include information from UniProtKB.
Protein type: Protein kinase, TK; EC 220.127.116.11; Protein kinase, tyrosine (receptor); Kinase, protein; Membrane protein, integral; TK group; InsR family
Molecular Function: identical protein binding; insulin-like growth factor binding; nucleotide binding; G-protein alpha-subunit binding; transmembrane receptor protein tyrosine kinase activity; insulin receptor binding; insulin-like growth factor receptor activity; protein kinase activity; transferase activity; insulin binding; protein binding; insulin-like growth factor I binding; insulin receptor substrate binding; protein-tyrosine kinase activity; phosphoinositide 3-kinase binding; kinase activity; ATP binding
Biological Process: positive regulation of DNA metabolic process; epidermis development; inactivation of MAPKK activity; protein heterooligomerization; positive regulation of smooth muscle cell proliferation; protein amino acid autophosphorylation; exocrine pancreas development; protein amino acid phosphorylation; regulation of JNK cascade; positive regulation of MAPKKK cascade; mammary gland development; male sex determination; protein tetramerization; neurite development; positive regulation of cytokinesis; positive regulation of axon regeneration; negative regulation of protein kinase B signaling cascade; phosphoinositide-mediated signaling; positive regulation of mitosis; negative regulation of MAPKKK cascade; negative regulation of transcription factor activity; positive regulation of phosphoinositide 3-kinase cascade; positive regulation of protein kinase B signaling cascade; organ morphogenesis; axonogenesis; insulin-like growth factor receptor signaling pathway; establishment of cell polarity; positive regulation of osteoblast proliferation; immune response; brain development; phosphorylation; transmembrane receptor protein tyrosine kinase signaling pathway; positive regulation of DNA replication; negative regulation of apoptosis; positive regulation of cell migration
LTP: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.